Semanteon Capital Management, LP
Position in CRNX — Crinetics Pharmaceuticals, Inc.
CIK 1738809
NEWTON, MA
Position in CRNX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$202,011
New position
Shares Held
5,562
first reported quarter
Ownership
0.005%
of shares outstanding
% of Portfolio
2.85%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Semanteon Capital Management, LP holds $234,868 across 1 Biotechnology name.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TGTX |
Tg Therapeutics, Inc.
|
4,275 | $234,868 |
All Filings in CRNX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $202,011 | 5,562 | Shares | Sole | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||